GlaxoSmithKline, LLC | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2013 | MD-AG | $15,000,000 |
GLAXOSMITHKLINE, LLC | GlaxoSmithKline | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550 |
GlaxoSmithKline Vaccines | GlaxoSmithKline | environmental violation | 2014 | EPA | $172,900 |
GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
GlaxoSmithKline plc | GlaxoSmithKline | kickbacks and bribery | 2016 | SEC | $20,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $35,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $49,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $150,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $92,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $100,000,000 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $65,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | environmental violation | 2014 | EPA | $317,550 |
GlaxoSmithKline LLC | GlaxoSmithKline | drug or medical equipment safety violation | 2012 | MULTI-AG | $90,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
GLAXOSMITHKLINE LLC | GlaxoSmithKline | environmental violation | 2016 | PA-ENV | $5,259 |
GlaxoSmithKline LLC | GlaxoSmithKline | environmental violation | 2015 | NY-ENV | $24,200 |
GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | tax violations | 2006 | IRS | $3,400,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2006 | GA-AG | $418,952 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
GlaxoSmithKline | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $70,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $770,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2009 | private lawsuit-federal | $28,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2006 | private lawsuit-state | $63,833,148 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2004 | private lawsuit-federal | $175,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
GlaxoSmithKline | GlaxoSmithKline | price-fixing or anti-competitive practices | 2023 | IN-AG | $1,270,000 |
GLAXO SMITH KLINE | GlaxoSmithKline | aviation safety violation | 2014 | FAA | $59,500 |
Gilead Sciences, Inc. | Gilead Sciences | False Claims Act and related | 2020 | DOJ_CIVIL | $97,000,000 |
Gilead Sciences | Gilead Sciences | False Claims Act and related | 2013 | LA-AG | $250,000 |
Gilead Sciences | Gilead Sciences | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $246,750,000 |
GILEAD SCIENCES | Gilead Sciences | workplace safety or health violation | 2000 | OSHA | $5,700 |
Genzyme Corporation | Sanofi | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
Geneva Pharmaceuticals | Novartis | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $15,350,000 |
General Nutrition Corporation | Harbin Pharmaceutical Group | wage and hour violation | 2017 | MA-AG | $72,304 |
General Nutrition Corporation | Harbin Pharmaceutical Group | employment discrimination | 2019 | private lawsuit-federal | $550,187 |
GENERAL NUTRITION CORPORATION | Harbin Pharmaceutical Group | workplace safety or health violation | 2019 | OSHA | $7,674 |
General Nutrition Corp. | Harbin Pharmaceutical Group | consumer protection violation | 2002 | FL-AG | $1,000,000 |
General Nutrition Centers Inc. | Harbin Pharmaceutical Group | consumer protection violation | 2019 | private lawsuit-federal | $6,000,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2016 | private lawsuit-federal | $9,000,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2015 | private lawsuit-federal | $350,014 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2007 | private lawsuit-federal | $1,910,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2005 | private lawsuit-federal | $60,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2005 | private lawsuit-state | $4,600,000 |
Genentech Inc. | Roche | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
Genentech Inc. | Roche | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
Genentech Inc. | Roche | off-label or unapproved promotion of medical products | 2000 | MULTI-AG | $19,000,000 |
Genentech | Roche | wage and hour violation | 2012 | private lawsuit-state | $2,100,000 |
Genentech | Roche | wage and hour violation | 2011 | private lawsuit-state | $2,600,000 |
Genentech | Roche | environmental violation | 2023 | EPA | $158,208 |
GENENTECH | Roche | workplace safety or health violation | 2003 | OSHA | $11,240 |
Genentech | Roche | environmental violation | 2023 | EPA | $158,209 |
Galena Biopharma, Inc. | SELLAS Life Sciences Group | accounting fraud or deficiencies | 2017 | SEC | $200,000 |
Galena Biopharma Inc. | SELLAS Life Sciences Group | False Claims Act and related | 2017 | USAO | $7,550,000 |
Fujisawa Healthcare, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Fort Dodge Animal Health | Zoetis | economic sanction violation | 2004 | OFAC | $26,956 |
Forest Pharmaceuticals Inc. | AbbVie | off-label or unapproved promotion of medical products | 2011 | FDA | $164,000,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2010 | USAO | $149,000,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $60,000,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
Forest Laboratories, Inc. | AbbVie | employment discrimination | 2018 | private lawsuit-federal | $4,000,000 |
Forest Laboratories, Inc. | AbbVie | False Claims Act and related | 2012 | ID-AG | $790,000 |
Forest Laboratories LLC | AbbVie | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,500,000 |
Forest Laboratories LLC | AbbVie | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $750,000,000 |
Forest Laboratories LLC | AbbVie | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $27,200,000 |
Forest Laboratories Inc. | AbbVie | False Claims Act and related | 2019 | IL-AG | $7,089,034 |
Forest Laboratories Inc. | AbbVie | consumer protection violation | 2014 | private lawsuit-federal | $10,350,000 |
Forest Laboratories and Forest Pharmaceuticals | AbbVie | False Claims Act and related | 2016 | DOJ_CIVIL | $38,000,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
ExecuPharm, Inc. | Parexel International | Family and Medical Leave Act | 2017 | WHD | $5,900 |
ETHICON, INC. | Johnson & Johnson | workplace safety or health violation | 2017 | OSHA | $6,518 |
ETHICON, INC. | Johnson & Johnson | workplace safety or health violation | 2020 | OSHA | $9,832 |
ETHICON INC | Johnson & Johnson | environmental violation | 2009 | NJ-ENV | $5,250 |
ETHICON ENDO SURGERY | Johnson & Johnson | aviation safety violation | 2010 | FAA | $5,500 |
Ethicon | Johnson & Johnson | consumer protection violation | 2023 | KY-AG | $9,900,000 |
Eon Labs Inc. | Novartis | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals | Endo International | drug or medical equipment safety violation | 2015 | USAO | $39,000,000 |
Endo Pharmaceuticals Inc. | Endo International | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $60,000,000 |
Endo Pharmaceuticals Inc. | Endo International | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $40,000,000 |
Endo Pharmaceuticals | Endo International | consumer protection violation | 2019 | CA-AG | $760,000 |
Endo Pharmaceuticals | Endo International | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Endo Pharmaceuticals | Endo International | Controlled Substances Act violation | 2020 | OK-AG | $8,750,000 |
Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $10,000,000 |